info@seagull-health.com
SeagullHealth
语言:
search

Rubraca(Rucaparib) Side Effects

Rubraca may cause a range of side effects, especially hematologic and gastrointestinal issues.

Side Effects of Rubraca

The most common side effects associated with Rubraca include hematologic abnormalities such as anemia, neutropenia, and thrombocytopenia, which may require dose reduction or discontinuation of treatment. Gastrointestinal issues such as nausea, fatigue, and decreased appetite have also been reported. Other less frequent but serious side effects may include liver enzyme elevation and myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) in some patients. Close monitoring of blood counts and liver function is essential during treatment with Rubraca to mitigate these risks. Specific rare side effects are not specified in the description.

Rucaparib(Rubraca)
Rucaparib(Rubraca)
Adult patients with BRCA-mutated advanced ovarian cancer who have previously...
WeChat Scan
Free Inquiry
Related articles
What side effects can Rucaparib cause?
Rucaparib is an orally active and potent inhibitor of polyadenosine diphosphate ribose polymerase (PARP). It is suitable for maintenance therapy of BRCA-mutated recurrent ovarian disease and BRCA...
Side effects of Rucaparib
Rucaparib is a PARP inhibitor for the treatment of BRCA mutation-associated ovarian and prostate cancers, with significant efficacy and a variety of side effects, which are described in detail be...
How to alleviate Rucaparib side effects?
Rucaparib is a PARP inhibitor widely used in the treatment of BRCA mutation-associated ovarian and prostate cancers. However, there may be a variety of adverse reactions during its use, such as n...
共 3 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved